The first phase of the establishment of the Centre for Bio-equivalence, which will support local pharmaceutical industries to obtain World Health Organisation (WHO) pre-qualification for their products by testing the match of a generic drug with the originator product, is to start immediately The centre is expected to be housed at the already existing 60-bed […]
Read Full Story
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS